We are live on ! Find out more
DSGN icon

Design Therapeutics
DSGN

83 hedge funds and large institutions have $413M invested in Design Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

371% more call options, than puts

Call options by funds: $5.82M | Put options by funds: $1.24M

36% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 14

26% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 23

5% more funds holding

Funds holding: 79 → 83 (+4)

2% less ownership

Funds ownership: 74.2% → 72.2% (-2%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

40% less capital invested

Capital invested by funds: $692M → $413M (-$280M)

Holders
83
Holders Change
+4
Holders Change %
+5.06%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
19
Increased
29
Reduced
23
Closed
14
Calls
$5.82M
Puts
$1.24M
Net Calls
+$4.58M
Net Calls Change
-$2.2M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$28.8M
2
SOCM
SR One Capital Management
Pennsylvania
+$12.2M
3
Millennium Management
Millennium Management
New York
+$5.09M
4
Bank of America
Bank of America
North Carolina
+$3.1M
5
Rafferty Asset Management
Rafferty Asset Management
New York
+$2.88M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$25.8M
2
EC
EcoR1 Capital
California
-$22.1M
3
BBA
Baker Bros. Advisors
New York
-$10.1M
4
Goldman Sachs
Goldman Sachs
New York
-$9.75M
5
TCM
Tekla Capital Management
Massachusetts
-$4.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.3M +$17.3K +1,277 +1%
Marshall Wace
27
Marshall Wace
United Kingdom
$1.16M +$1.53M +112,818 New
Citigroup
28
Citigroup
New York
$1.13M +$1.02M +75,393 +220%
CSS
29
Cubist Systematic Strategies
Connecticut
$1.12M +$1.48M +109,303 New
N
30
Nuveen
North Carolina
$965K -$218K -16,062 -15%
GTC
31
Ghost Tree Capital
New York
$850K -$232K -17,147 -17%
Acadian Asset Management
32
Acadian Asset Management
Massachusetts
$594K +$785K +57,957 New
SCM
33
Silverarc Capital Management
Massachusetts
$585K +$773K +57,025 New
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$530K -$2.11K -156 -0.3%
ECM
35
ExodusPoint Capital Management
New York
$521K -$15K -1,110 -2%
Morgan Stanley
36
Morgan Stanley
New York
$425K -$237K -17,511 -30%
Two Sigma Investments
37
Two Sigma Investments
New York
$360K +$476K +35,093 New
BG
38
Bellevue Group
Switzerland
$358K – – –
JF
39
Jump Financial
Illinois
$312K +$412K +30,400 New
AllianceBernstein
40
AllianceBernstein
Tennessee
$283K +$86.7K +6,400 +30%
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$251K +$2.98K +220 +0.9%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$251K +$83.2K +6,140 +34%
MIM
43
MetLife Investment Management
New Jersey
$226K – – –
JP Morgan Chase
44
JP Morgan Chase
New York
$203K -$994K -73,352 -79%
Deutsche Bank
45
Deutsche Bank
Germany
$183K +$55.3K +4,082 +30%
Tudor Investment Corp
46
Tudor Investment Corp
Connecticut
$181K -$138K -10,182 -37%
AIG
47
American International Group
New York
$164K -$800 -59 -0.4%
Mitsubishi UFJ Asset Management
48
Mitsubishi UFJ Asset Management
Japan
$163K +$226K +16,689 New
VEA
49
Virtus ETF Advisers
New York
$162K +$108K +7,999 +103%
Mirae Asset Global Investments
50
Mirae Asset Global Investments
South Korea
$160K +$298 +22 +0.1%
1
2
3 4

DSGN Hedge Fund Activity: Q4 2022 in Review

83 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Design Therapeutics (DSGN) for Q4 2022, worth a combined $413M — down 40% from $692M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new DSGN positions and 14 closed out — a net gain of 5 holders — while 29 added to existing stakes and 23 trimmed.

The largest buyer was State Street, adding an estimated $28.8M. The largest seller was Janus Henderson Group, cutting an estimated $25.8M.

  • 83 institutional investors held Design Therapeutics (DSGN) as of Q4 2022, up from 79 in Q3 2022.
  • Funds reported $413M of Design Therapeutics stock for Q4 2022, down 40% quarter-over-quarter.
  • 19 funds opened new Design Therapeutics positions in Q4 2022 and 14 closed out, a net change of +5 holders.
  • The largest Design Therapeutics buyer in Q4 2022 was State Street, an estimated $28.8M added.
  • The largest Design Therapeutics seller in Q4 2022 was Janus Henderson Group, an estimated $25.8M sold.

Based on aggregated 13F filings for Q4 2022.